The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response—Biological and Clinical Aspects
Radiation therapy remains an imperative treatment modality for numerous malignancies. Enduring significant technical achievements both on the levels of treatment planning and radiation delivery have led to improvements in local control of tumor growth and reduction in healthy tissue toxicity. Nevert...
Main Authors: | Michaela Medová, Daniel M. Aebersold, Yitzhak Zimmer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/6/1/1 |
Similar Items
-
Deciphering MET‐dependent modulation of global cellular responses to DNA damage by quantitative phosphoproteomics
by: Ariel Bensimon, et al.
Published: (2020-06-01) -
The MET Receptor Tyrosine Kinase Is a Potential Therapeutic Target in Combination with Radiation in Head and Neck Squamous Cell Carcinoma
by: Wu, Ronald
Published: (2012) -
The MET Receptor Tyrosine Kinase Is a Potential Therapeutic Target in Combination with Radiation in Head and Neck Squamous Cell Carcinoma
by: Wu, Ronald
Published: (2012) -
Altering DNA Repair to Improve Radiation Therapy: Specific and Multiple Pathway Targeting
by: Julian Biau, et al.
Published: (2019-10-01) -
Effects of Radiation Intensity, Mineral Matrix, and Pre-Irradiation on the Bacterial Resistance to Gamma Irradiation under Low Temperature Conditions
by: Vladimir S. Cheptsov, et al.
Published: (2021-01-01)